Revelation Biosciences Inc - Warrant — Financial Statements (NASDAQ:REVBW)

Financials

Total revenue —————-11.21 K — Gross profit ————-1.62 M-1.6 M -1.59 M Operating expenses 145.49 K3.09 M10.86 M8.66 M7.98 M9.07 M 9.07 M Selling/general/admin expenses 145.49 K3.09 M5.49 M4.51 M4.43 M5.01 M 5.01 M Research & development ——5.38 M4.15 M3.55 M4.06 M 4.06 M Operating income -145.49 K-3.09 M-10.86 M-8.66 M-7.98 M-9.07 M -9.07 M Non-Operating Income, Total 18.41 K957.84 K34.96 K8.54 M-7.06 M157.16 K 157.16 K Interest expense, net of interest capitalized —41.76 K———— — Non-Operating Income, excl. Interest Expenses 9 325-41.54 K08.33 M81.44 K2 158 2 158 Unusual income/expense 9 084957.62 K34.96 K207.47 K-7.14 M155.01 K 155.01 K Pretax income 136.41 K-2.13 M-10.83 M-120.25 K-15.04 M-8.91 M -8.91 M Equity in earnings —————— — Taxes 0—0000 0 Non-controlling/minority interest —————— — After tax other income/expense —————— — Net income before discontinued operations 136.41 K-2.13 M10.8 M100 K-15.04 M-8.91 M -8.91 M Discontinued operations —————— — Net income 136.41 K-2.13 M10.8 M100 K-15.04 M-8.91 M -8.91 M Dilution adjustment —2.14 M———— — Preferred dividends —6 896———— — Diluted net income available to common stockholders 136.41 K6 89610.8 M100 K-15.04 M-14.87 M -14.87 M Basic earnings per share (Basic EPS) —-235.87 K-115.72 K-101.76-1 052.16-23.95 -23.95 Diluted earnings per share (Diluted EPS) —-236.07 K-115.72 K-101.76-1 052.16-23.95 -23.95 Average basic shares outstanding —9.0393.581 190.8414.29 K620.78 K 1.56 M Diluted shares outstanding —9.0393.581 190.8414.29 K620.78 K 1.56 M EBITDA —————-10.65 M — EBIT —————-10.67 M — Cost of revenue ————1.62 M1.59 M 1.59 M Other cost of goods sold ————1.62 M1.59 M 1.59 M Depreciation & amortization (cash flow) ——25.05 K25.05 K27.92 K27.06 K 27.06 K